A new prebiotic from germinated barley for nutraceutical treatment of ulcerative colitis
- PMID: 12164955
- DOI: 10.1046/j.1440-1746.2002.02709.x
A new prebiotic from germinated barley for nutraceutical treatment of ulcerative colitis
Abstract
A germinated barley foodstuff (GBF) containing glutamine-rich protein and hemicellulose-rich fiber was made from brewer's spent grain, by physical isolation. Our previous studies demonstrated that GBF supported maintenance of epithelial cell populations, facilitated epithelial repair, and suppressed epithelial nuclear factor kappaB-DNA-binding activity through generating increased short-chain fatty acid (especially butyrate) production by luminal microflora, which includes Bifidobacterium and Eubacterium, thereby preventing experimental colonic injury. The fiber fraction also modulates stool water content because of its high water-holding capacity. The patients with mild to moderate active ulcerative colitis who had been unresponsive to or intolerant of standard treatment received 20-30 g GBF, feeding daily in a non-randomized, open-label fashion. At 4 weeks, this treatment resulted in a significant clinical and endoscopic improvement. The improvement was associated with an increase in stool butyrate concentrations. These results indicate that GBF feeding is a potentially new, attractive prebiotic treatment in patients with ulcerative colitis. The potency of GBF on modulating microflora, as well as the high water-holding capacity, may play an important role in treatment and prolongation of remission in ulcerative colitis.
Similar articles
-
Germinated barley foodstuff feeding. A novel neutraceutical therapeutic strategy for ulcerative colitis.Digestion. 2001;63 Suppl 1:60-7. doi: 10.1159/000051913. Digestion. 2001. PMID: 11173912 Clinical Trial.
-
Dietary fiber fraction of germinated barley foodstuff attenuated mucosal damage and diarrhea, and accelerated the repair of the colonic mucosa in an experimental colitis.J Gastroenterol Hepatol. 2001 Feb;16(2):160-8. doi: 10.1046/j.1440-1746.2001.02427.x. J Gastroenterol Hepatol. 2001. PMID: 11207896
-
Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment.Int J Mol Med. 2002 Jan;9(1):65-70. Int J Mol Med. 2002. PMID: 11744999
-
Modification of intestinal flora in the treatment of inflammatory bowel disease.Curr Pharm Des. 2003;9(4):333-46. doi: 10.2174/1381612033391883. Curr Pharm Des. 2003. PMID: 12570821 Review.
-
The beneficial effects of microflora, especially obligate anaerobes, and their products on the colonic environment in inflammatory bowel disease.Curr Pharm Des. 2005;11(8):1047-53. doi: 10.2174/1381612053381675. Curr Pharm Des. 2005. PMID: 15777254 Review.
Cited by
-
Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases.Int J Mol Sci. 2021 Apr 22;22(9):4377. doi: 10.3390/ijms22094377. Int J Mol Sci. 2021. PMID: 33922158 Free PMC article. Review.
-
Herbal medicine in the treatment of ulcerative colitis.Saudi J Gastroenterol. 2012 Jan-Feb;18(1):3-10. doi: 10.4103/1319-3767.91726. Saudi J Gastroenterol. 2012. PMID: 22249085 Free PMC article. Review.
-
Components of the Fiber Diet in the Prevention and Treatment of IBD-An Update.Nutrients. 2022 Dec 29;15(1):162. doi: 10.3390/nu15010162. Nutrients. 2022. PMID: 36615818 Free PMC article. Review.
-
Prebiotic treatment reduced preneoplastic lesions through the downregulation of toll like receptor 4 in a chemo-induced carcinogenic model.J Clin Biochem Nutr. 2011 Jul;49(1):57-61. doi: 10.3164/jcbn.10-114. Epub 2011 May 14. J Clin Biochem Nutr. 2011. PMID: 21765608 Free PMC article.
-
Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis.World J Gastroenterol. 2015 May 21;21(19):5985-94. doi: 10.3748/wjg.v21.i19.5985. World J Gastroenterol. 2015. PMID: 26019464 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical